Searched over 200M research papers
10 papers analyzed
Some studies suggest losartan can lower heart rate, particularly in specific conditions like salt depletion and myocardial infarction, while other studies indicate it primarily improves heart rate variability and autonomic modulation without a direct effect on heart rate.
20 papers analyzed
Losartan, an angiotensin II receptor antagonist, is widely used for managing hypertension and heart failure. One of the key areas of interest is its effect on heart rate. This article synthesizes findings from multiple studies to provide a clear understanding of how losartan influences heart rate.
Research has shown that losartan can lower heart rate in patients with symptomatic heart failure. A study involving multiple doses of losartan (2.5, 10, 25, and 50 mg) demonstrated that heart rate was reduced across all active treatment groups over a 12-week period. This indicates that losartan has a consistent effect on lowering heart rate in heart failure patients.
Losartan has also been found to improve heart rate variability (HRV) and heart rate turbulence in patients with ischemic cardiomyopathy. In a study where patients were already on beta-blockers and ACE inhibitors, the addition of losartan significantly improved HRV parameters and heart rate turbulence indices over 12 weeks. This suggests that losartan not only lowers heart rate but also enhances the autonomic regulation of heart rate.
In hypertensive patients, losartan has been shown to maintain a significant vagal component during vasodilation, which is indicative of a favorable autonomic profile. A study involving hypertensive patients undergoing a tilt test and trinitroglycerine vasodilation found that losartan treatment resulted in a significant reduction in low-frequency power, which is associated with sympathetic activity, while maintaining heart rate variability. This suggests that losartan helps in balancing autonomic control, thereby potentially lowering heart rate.
When compared to other antihypertensive agents like verapamil and enalapril, losartan was found to be less effective in lowering heart rate over a 24-hour period. A study comparing controlled-onset, extended-release verapamil, enalapril, and losartan found that verapamil was the only treatment to significantly lower heart rate over both the 24-hour period and during waking hours. This indicates that while losartan does lower heart rate, it may not be as potent as some other antihypertensive medications in this regard.
Losartan's ability to lower heart rate is partly due to its influence on the autonomic nervous system. In a study on rats with myocardial infarction, losartan was found to potentiate the heart rate response to vagal nerve stimulation, indicating an enhancement of parasympathetic activity. This suggests that losartan may help in restoring the balance between sympathetic and parasympathetic nervous systems, leading to a reduction in heart rate.
In nonhuman primates, losartan was shown to inhibit both endogenous and exogenous angiotensin II stimulation, leading to a modest hypotension without significantly altering heart rate in normal conditions. However, in sodium-depleted conditions, losartan caused a decrease in arterial pressure and an increase in plasma renin activity without significantly changing heart rate. This indicates that losartan's effect on heart rate may be context-dependent, influenced by the body's hormonal and fluid balance.
Losartan has a multifaceted impact on heart rate, particularly in patients with heart failure and hypertension. It consistently lowers heart rate in heart failure patients and improves heart rate variability, indicating enhanced autonomic regulation. While it may not be as effective as some other antihypertensive agents in lowering heart rate over a 24-hour period, its ability to balance autonomic control and influence hormonal responses makes it a valuable option in cardiovascular therapy.
Most relevant research papers on this topic